Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A modern heart transplant rejection surveillance protocol utilizing cell-free DNA: A single-center experience

2 Mar 2024

Abstract excerpt

BACKGROUND: Endomyocardial biopsy (EMBx) is considered the gold standard for rejection monitoring after heart transplantation; however, it is invasive and histologic interpretation has limitations. Sensitive blood biomarkers, including donor-derived cell-free DNA (dd-cfDNA), have emerged to decrease EMBx frequency. METHODS: We retrospectively reviewed data on 237 patients who underwent heart transplantation at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Organ and Tissue Transplantation Research
Share to Renal Transplantation Outcomes and Treatments
Share to Transplantation: Methods and Outcomes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40144235
DOI: 10.1016/j.jhlto.2024.100076

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A modern heart transplant rejection surveillance protocol utilizing cell-free DNA: A single-center experiencePMID 40144235Read ↗

A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantationSemantic proximity Read ↗

Absolute quantification of donor-derived cell-free DNA following pediatric and adult heart transplantationSemantic proximity Read ↗

Rejection Surveillance: Integrating Cell-Free DNA and Gene Expression Panels to Decrease Invasiveness in Routine Monitoring of Heart Transplant RecipientsSemantic proximity Read ↗

Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant RejectionSemantic proximity Read ↗

Graft-derived Cell-free DNA as a Noninvasive Biomarker of Cardiac Allograft Rejection: A Cohort Study on Clinical Validity and Confounding FactorsSemantic proximity Read ↗

A two-threshold algorithm using donor-derived cell-free DNA fraction and quantity to detect acute rejection after heart transplantationSemantic proximity Read ↗

Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney TransplantSemantic proximity Read ↗

Utility of Plasma Cell-free Chromatin Immunoprecipitation to Detect Cardiac Allograft RejectionSemantic proximity Read ↗

Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probabilitySemantic proximity Read ↗

Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter studySemantic proximity Read ↗

Universal noninvasive detection of solid organ transplant rejection.Semantic proximity Read ↗

Comparing Plasma Donor–derived Cell-free DNA to Gene Expression in Endomyocardial Biopsies in the Trifecta-Heart StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.